Wondering why treatment works for some people and not others? According to Dr. Brian Druker, director of the Knight Cancer Institute at Oregon Health & Science University, it all comes down to “precision medicine” – the ability to use genome sequencing and molecular imaging to create a treatment plan tailored to each individual. Click here to read his article which appears in Fortune magazine in October.
Dr. Brian Druker, developer of Gleevec, writes about "precision medicine."
